July 14, 2022 10:44 AM EDT

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Hal Barron’s anti-aging biotech has added Vir Biotechnology CSO Herbert “Skip” Virgin to its ranks. At the Rick Klausner-founded Altos Labs, Virgin will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Sign up to read this article for free.

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

Updated: Novo’s 23% weight loss with CagriSema falls short of high expectations, new trial planned

Sofinnova outlines $550M fund after IPOs and M&A deals

Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients

FDA approves Humacyte’s lab-grown blood vessels in milestone for regenerative medicine

GSK's Zejula-Jemperli combo in ovarian cancer hits primary endpoint, misses on overall survival

Vir CSO de­part­ing next month to be Al­tos CMO; Bob Dug­gan’s Sum­mit Ther­a­peu­tics and the FDA try to make head­way

Senior Reporter

News Reporter

Sign up to read this article for free.

more like this

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway